Osteopontin expression correlates with invasiveness in cervical cancer

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 49, Issue 4, 2009, Pages 434-438

  Song, Jae Yun ^a   Lee, Jae Kwan ^a   Lee, Nak Woo ^a   Yeom, Bom Woo ^a   Kim, Sun Haeng ^a   Lee, Kyu Wan ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Immunohistochemistry; Neoplastic cell transformation; Osteopontin; Tissue array analysis; Uterine cervical neoplasms

Indexed keywords

OSTEOPONTIN; TUMOR MARKER;

ARTICLE; CANCER INVASION; CANCER SURVIVAL; CARCINOGENESIS; CARCINOMA IN SITU; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; UTERINE CERVIX CANCER;

CARCINOMA IN SITU; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OSTEOPONTIN; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 70350192257     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2009.01027.x     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350.
3. Thomas M, Pim D, Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 1999; 18: 7690-7700.
4. Chen TM, Pecoraro G, Defendi V. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res 1993; 53: 1167-1171.
5. Senger DR, Wirth DF, Hynes RO. Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell 1979; 16: 885-893.
6. Tuck AB, Chambers AF. The role of osteopontin in breast cancer: Clinical and experimental studies. J Mammary Gland Biol Neoplasia 2001; 6: 419-429.
7. Wai PY, Kuo PC. The role of osteopontin in tumor metastasis. J Surg Res 2004; 121: 228-241.
8. Weber GF. The metastasis gene osteopontin: A candidate target for cancer therapy. Biochim Biophys Acta 2001; 1552: 61-85.
9. Rittling SR, Chambers AF. Role of osteopontin in tumour progression. Br J Cancer 2004; 90: 1877-1881.
10. Agrawal D, Chen T, Irby R et al. Osteopontin identified as colon cancer tumor progression marker. C R Biol 2003; 326: 1041-1043.
11. Donati V, Boldrini L, Dell'Omodarme M et al. Osteopontin expression and prognostic significance in non-small cell lung cancer. Clin Cancer Res 2005; 11: 6459-6465. (Pubitemid 41338982)
12. Forootan SS, Foster CS, Aachi VR et al. Prognostic significance of osteopontin expression in human prostate cancer. Int J Cancer 2006; 118: 2255-2261.
13. Higashiyama M, Ito T, Tanaka E, Shimada Y. Prognostic significance of osteopontin expression in human gastric carcinoma. Ann Surg Oncol 2007; 14: 3419-3427. (Pubitemid 350160128)
14. Tuck AB, Chambers AF, Allan AL. Osteopontin overexpression in breast cancer: Knowledge gained and possible implications for clinical management. J Cell Biochem 2007; 102: 859-868.
15. Wallach RC. Osteopontin as a biomarker for ovarian cancer. JAMA 2002; 287: 3209
16. author reply 3209-3210.
17. Song JY, Lee JK, Lee NW, Jung HH, Kim SH, Lee KW. Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: Identification of candidate genes in pathogenesis of invasion in cervical cancer. Int J Gynecol Cancer 2008; 18: 1051-1059.
18. O'Regan A, Berman JS. Osteopontin: A key cytokine in cellmediated and granulomatous inflammation. Int J Exp Pathol 2000; 81: 373-390.
19. Senger DR, Perruzzi CA. Secreted phosphoprotein markers for neoplastic transformation of human epithelial and fibroblastic cells. Cancer Res 1985; 45: 5818-5823.
20. Cho H, Hong SW, Oh YJ et al. Clinical significance of osteopontin expression in cervical cancer. J Cancer Res Clin Oncol 2008; 134: 909-917.
21. Sakaguchi H, Fujimoto J, Hong BL, Tamaya T. Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers. Cancer Lett 2007; 247: 98-102. (Pubitemid 44959409)
22. Rangaswami H, Bulbule A, Kundu GC. Osteopontin: Role in cell signaling and cancer progression. Trends Cell Biol 2006; 16: 79-87.
23. Fisher LW, Jain A, Tayback M, Fedarko NS. Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers. Clin Cancer Res 2004; 10: 8501-8511.
24. Matsuzaki H, Shima K, Muramatsu T et al. Osteopontin as biomarker in early invasion by squamous cell carcinoma in tongue. J Oral Pathol Med 2007; 36: 30-34.
25. Tozawa K, Yamada Y, Kawai N, Okamura T, Ueda K, Kohri K. Osteopontin expression in prostate cancer and benign prostatic hyperplasia. Urol Int 1999; 62: 155-158.
26. Kita Y, Natsugoe S, Okumura H et al. Expression of osteopontin in oesophageal squamous cell carcinoma. Br J Cancer 2006; 95: 634-638